SMAD3 Cancer Research Results
SMAD3, SMAD3: Click to Expand ⟱
| Source: |
| Type: |
Deletion or inhibition of Smad3 in the tumour microenvironment suppresses tumour growth, invasion and metastasis in two syngeneic mouse tumour models.
Smad3 promotes cancer progression by inhibiting E4BP4-mediated NK cell development.
|
Nor, Normal Healthy: Click to Expand ⟱
Scientific Papers found: Click to Expand⟱
| - |
in-vitro, |
Lung, |
A549 |
|
|
|
- |
in-vitro, |
Nor, |
BEAS-2B |
|
|
|
HMGB1↓, EMT↓, TumCMig↓, p‑SMAD2↓, p‑SMAD3↓,
*Akt↑, *AMPK↓, *TGF-β↓, eff↑, *BioEnh↑, *ATP↑, *PGC-1α↑, *p‑mTOR↑, *SMAD3↓,
| - |
Trial, |
BC, |
NA |
|
|
|
- |
in-vitro, |
BC, |
MCF-7 |
|
|
|
- |
in-vitro, |
Nor, |
C2C12 |
|
|
|
TumCP↓, TumCMig↓, TumCI↓, *toxicity∅, TGF-β↓, Twist↓, Slug↓, β-catenin/ZEB1↓, Vim↓, p‑SMAD2↓, p‑SMAD3↓, angioG↓, VEGF↓, selectivity↑, LIF↑,
*ROS↓, *p‑Smad1↑, *p‑SMAD5↑, *SMAD2↓, *SMAD3↓, *p‑ERK↓, *p‑Cofilin↓,
Showing Research Papers: 1 to 4 of 4
* indicates research on normal cells as opposed to diseased cells
Total Research Paper Matches: 4
Pathway results for Effect on Cancer / Diseased Cells:
Proliferation, Differentiation & Cell State ⓘ
EMT↓, 1,
Migration ⓘ
Slug↓, 1, p‑SMAD2↓, 2, p‑SMAD3↓, 2, TGF-β↓, 1, TumCI↓, 1, TumCMig↓, 2, TumCP↓, 1, Twist↓, 1, Vim↓, 1, β-catenin/ZEB1↓, 1,
Angiogenesis & Vasculature ⓘ
angioG↓, 1, VEGF↓, 1,
Immune & Inflammatory Signaling ⓘ
HMGB1↓, 1, LIF↑, 1,
Drug Metabolism & Resistance ⓘ
eff↑, 1, selectivity↑, 1,
Total Targets: 17
Pathway results for Effect on Normal Cells:
Redox & Oxidative Stress ⓘ
ROS↓, 1,
Mitochondria & Bioenergetics ⓘ
ATP↑, 1, PGC-1α↑, 1,
Core Metabolism/Glycolysis ⓘ
AMPK↓, 1,
Cell Death ⓘ
Akt↑, 1,
Proliferation, Differentiation & Cell State ⓘ
p‑ERK↓, 1, p‑mTOR↑, 1,
Migration ⓘ
p‑Cofilin↓, 1, p‑Smad1↑, 1, SMAD2↓, 1, SMAD3↓, 2, p‑SMAD5↑, 1, TGF-β↓, 1,
Drug Metabolism & Resistance ⓘ
BioEnh↑, 1,
Functional Outcomes ⓘ
toxicity∅, 1,
Total Targets: 15
Scientific Paper Hit Count for: SMAD3, SMAD3
Query results interpretion may depend on "conditions" listed in the research papers.
Such Conditions may include :
-low or high Dose
-format for product, such as nano of lipid formations
-different cell line effects
-synergies with other products
-if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:% IllCat:% CanType:49 Cells:% prod#:% Target#:556 State#:% Dir#:1
wNotes=0 sortOrder:rid,rpid
Home Page